Upon reaching the tumor cells, chemotherapeutic drugs first bind to ABCB1, then ATP hydrolysis generates energy for pumping the drugs out of the cells, decreasing the concentration of intracellular drugs, and therefore leading to drug resistance (14–16). The gene discussed is ABCB1; the disease is neoplasm.